2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Penile Cancer
Penile cancer, though rare, is a serious malignancy with significant impacts on male health. Recent advances in cancer research have led to better understanding and management of this condition. Studies have identified key risk factors, such as human papillomavirus (HPV) infection, smoking, and poor hygiene. Research is focusing on HPV vaccination as a preventive measure, highlighting its potential to drastically reduce incidence rates. Innovations in diagnostic techniques, including advanced imaging and molecular markers, enable earlier detection and more precise staging. Additionally, treatment options are evolving, with targeted therapies and immunotherapy showing promise in improving outcomes. Ongoing clinical trials continue to explore novel therapeutic approaches, aiming to enhance survival rates and quality of life for penile cancer patients.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China